- The Role of EGFR Tyrosine Kinase Inhibitors in the First-Line Treatment of Advanced Non Small Cell Lung Cancer Patients Harboring EGFR Mutation. Sgambato, A., Casaluce, F., Maione, P., Rossi, A., Rossi, E., Napolitano, A., Palazzolo, G., Bareschino, M.A., Schettino, C., Sacco, P.C., Ciadiello, F., Gridelli, C. Curr. Med. Chem. (2012)